Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T18:58:16.580Z.
Calculation as of: 2026-10-06T18:58:16.580Z.
Quote observation: 2026-10-06T18:50:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fd4e67db9f72c8f7e350226876d0b852307266b6ff0bede5899e1be1bde0c950
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Polaryx Therapeutics, Inc. Common Stock
Market Cap
$104.18M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.28M
EV/FCF Ratio
N/A
TTM Avg
15.12x
3Y Avg
15.12x
5Y Avg
15.12x
Market Cap
$104.00M
EV/FCF Ratio
N/A
TTM Avg
7.65x
3Y Avg
7.65x
5Y Avg
7.65x
Market Cap
$104.82M
EV/FCF Ratio
3.54x
TTM Avg
5.56x
3Y Avg
15.97x
5Y Avg
36.28x
Market Cap
$107.09M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Polaryx Therapeutics, Inc. Common Stock (PLYX) | $104.18M | N/A | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.28M | N/A | 15.12x | 15.12x | 15.12x |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | N/A | 7.65x | 7.65x | 7.65x |
| The Joint Corp. (JYNT)vs › | $102.67M | 19.52x | 87.97x | 49.68x | 56.25x |
| Definitive Healthcare Corp. (DH)vs › | $104.82M | 3.54x | 5.56x | 15.97x | 36.28x |
| OnKure Therapeutics, Inc. (OKUR)vs › | $101.85M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $107.06M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.44M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $109.23M | N/A | 22.94x | 13.31x | 10.37x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
